Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety

OBJECTIVE: Using mesenchymal stem cells (MSCs) is regarded as a new therapeutic approach for improving fibrotic diseases. the aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs (AD-MSCs) in peritoneal dialysis (PD) patients with ex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell J
Autors principals: Alatab, Sudabeh, Shekarchian, Soroosh, Najafi, Iraj, Moghadasali, Reza, Ahmadbeigi, Naser, Pourmand, Mohammad Reza, Bolurieh, Tina, Jaroughi, Neda, Pourmand, Gholamreza, Aghdami, Nasser
Format: Artigo
Idioma:Inglês
Publicat: Royan Institute 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099152/
https://ncbi.nlm.nih.gov/pubmed/30123994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22074/cellj.2019.5591
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars